Abstract
Certain compounds such as SC-52151 have extensive nonspecific adsorption to the ultrafiltration devices or to dialysis membranes and therefore can not be measured by the conventional ultrafiltration or equilibrium dialysis methods. A new method based on charcoal adsorption was developed to overcome this difficulty. Unlike many conventional methods, which are based on the separation of free drug from bound drug under equilibrium conditions, the new method is operated under nonequilibrium conditions and involves measuring the time course of decline of the percentage of bound drug remaining in plasma while the free drug is being removed by charcoal adsorption. Theoretical aspects of the method and the data processing procedure are presented. SC-98A, a compound with minimal nonspecific adsorption to the ultrafiltration membrane, was used to demonstrate the applicability of this method against the ultrafiltration method. Using this method, the protein binding of SC-52151 in human plasma at 1.0 μg/ml was determined to be in the range of 91.4–97.7% at room temperature.
Similar content being viewed by others
References
L. Shargel and A. B. C. Yu.Applied Biopharmaceutics and Pharmacokinetics, 2nd ed., Appleton-Century-Crofts, Norwalk, CT, 1985, pp. 197–211.
J. B. Whitlan and K. F. Brown. Ultrafiltration in serum protein binding determinations.J. Pharm. Sci. 70:146–150 (1981).
J. Kurz, J. Trunk, and B. Weitz. Evaluation of methods to determine protein-binding of drugs, equilibrium dialysis, ultrafiltration, ultracentrifugation, and gel filtration.Drug Res. 27:1373–1380 (1977).
G. W. Moll and R. L. Rosenfeld. Some limitations of using equilibrium dialysis to study human serum albumin-testosterone interaction.J. Clin. Endocrinal. Metab. 46:501–503 (1978).
P. A. Bombardt, J. E. Brewer, and M. G. Johnson. Protein binding of Tirilazad (U-74006) in human, Sprague-Dawley rat, Beagle dog and cynomolgus monkey serum.J. Pharmacol. Exp. Ther. 269:145–150 (1994).
D. P. Getman, G. A. DeCrescenzo, R. M. Heintz, K. L. Reed, J. J. Talley, M. L. Bryant, M. Clare, K. A. Houseman, J. J. Marr, R. A. Mueller, et al.. Discovery of a novel class of potent HIV-1 protease inhibitors containing the(R)-(hydroxyethyl)urea isostere.J. Med. Chem. 36:288–291 (1993).
V. Herbert, K. Lau, C. W. Gottlieb, and S. J. Bleicher. Coated charcoal immunoassay of insulin.J. Clin. Endocrinol. Metab. 25:1375–1384 (1965).
C. M. Metzler, G. K. Elfring and A. J. McEwen. A package of computer programs for pharmacokinetic modeling.Biometrics 30:562–563 (1974).
W. J. Jusko and M. Gretch. Plasma and tissue protein binding of drugs in pharmacokinetics.Drug Met. Rev. 5:43–140 (1976).
M. C. Meyer and D. E. Gutman. Dynamic dialysis as a method for studying protein binding II: Evaluation of the method with a number of binding systems.J. Pharm. Sci. 59:39–48 (1970).
M. C. Meyer and D. E. Gutman. Novel method for studying protein binding.J. Pharm. Sci. 57:1627–1629 (1968).
J. S. Robertson and B. W. Madsen. Kinetic approach to drug-protein binding.J. Pharm. Sci. 63:234–239 (1974).
J. Jacobesen and O. Fedders. Determination of non-albumin-bound bilirubin in human serum.J. Clin. Lab. Invest. 26:237–241 (1970).
A. Sevenson, E. Holmer, and L. Andersson. A new method for the measurement of dissociation rates for complexes between small ligands and proteins as applied to the palmitate and bilirubin complexes with serum albumin.Biochim. Byophys. Acta 342:54–59 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yuan, J., Yang, D.C., Birkmeier, J. et al. Determination of protein binding byin vitro charcoal adsorption. Journal of Pharmacokinetics and Biopharmaceutics 23, 41–55 (1995). https://doi.org/10.1007/BF02353785
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02353785